September 2025
1. MADHUSUDHAN K, Padmanaban A, Parvathi VD
   Early detection of Parkinson's disease via aptamer-CRISPR platform.
   Neuroscience. 2025 Sep 20:S0306-4522(25)00951.
   

   >> Share

   
   
2. BAO W, Ge Y, Huang J, Li Y, et al
   DJ-1/PARK7 in Parkinson's disease: mechanisms of pathogenesis and therapeutic potential.
   Neuroscience. 2025 Sep 19:S0306-4522(25)00949.
   

   >> Share

   
   
3. SINGH H, Kumari S, Taliyan R
   Epigenetic mechanisms linking environmental exposure to Parkinson's disease: A comprehensive review.
   Neuroscience. 2025;585:367-380.
   

   >> Share

   
   
4. ZHIDAN L, Xianjie L, Shulin S, Qiang J, et al
   TREM2 mediates parkinsonism-like neurodegeneration in carbon disulfide-induced neurotoxicity.
   Neuroscience. 2025;585:50-59.
   

   >> Share

   
   August 2025
5. ATANASOVSKI D, Bergquist F, Eriksson E, Carlsson T, et al
   The dopamine stabilizer (-)-OSU6162 attenuates levodopa-induced dyskinesia in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
   Neuroscience. 2025 Aug 23:S0306-4522(25)00889.
   

   >> Share

   
   
6. DA SILVA CHAAR NETA R, da Silva Batista C, Machado Palmerim EM, Costa Dias HM, et al
   The impact of social isolation due to the COVID-19 pandemic on functional performance, fall risk, and gait in individuals with Parkinson's Disease: a systematic review.
   Neuroscience. 2025;584:113-126.
   

   >> Share

   
   
7. GWEDELA MNV, Gadama Y, Phiri TE
   Parkinson's disease in Malawi: A cross-sectional Study of clinical profiles and risk factors.
   Neuroscience. 2025;584:88-92.
   

   >> Share

   
   July 2025
8. WANG B, Zhao Z, Guo RN, Wu X, et al
   Enhanced focality and intensity in deep brain targeting: In silico study on multi-channel temporal interference stimulation for Parkinson's disease.
   Neuroscience. 2025;582:72-81.
   

   >> Share

   
   
9. SONG J, Wang X, Dong L, Hui S, et al
   Identification of differentially co-expressed genes with lipid metabolism in Parkinson's disease by bioinformatics analysis.
   Neuroscience. 2025;581:58-71.
   

   >> Share

   
   
10. YADAV S, Raj RG
    Parkinson's disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons.
    Neuroscience. 2025;581:1-15.
    

    >> Share

    
    June 2025
11. WANG Z, Liu Y, Li C, Qin K, et al
    Music-based intervention as a new therapeutic treatment for executive dysfunction in Parkinson's disease.
    Neuroscience. 2025;580:306-314.
    

    >> Share

    
    
12. HU L, Han J, Ma R, Cheng J, et al
    Cathodal high-definition transcranial direct current stimulation improves sleep and motor symptoms in Parkinson's disease with possible rapid eye movement sleep behaviors disorder: A pilot open-label study.
    Neuroscience. 2025 Jun 27:S0306-4522(25)00738.
    

    >> Share

    
    
13. ZABALA-GOMEZ O, Ibarretxe-Bilbao N, Tijero B, Gabilondo I, et al
    Fatigue brain network functional connectivity in Parkinson's disease.
    Neuroscience. 2025 Jun 3:S0306-4522(25)00674.
    

    >> Share

    
    May 2025
14. CHEN D, Jiang Y, Ge F, Liu X, et al
    High-frequency repetitive transcranial magnetic stimulation upregulates BDNF expression and promotes synaptogenesis in mouse models of Parkinson's disease.
    Neuroscience. 2025 May 30:S0306-4522(25)00671.
    

    >> Share

    
    
15. KUANG Z, Huang X, Wang M, Bu S, et al
    Thalamic free water elevation and its association with glymphatic dysfunction in Parkinson's disease: A cross-sectional and longitudinal study.
    Neuroscience. 2025 May 27:S0306-4522(25)00667.
    

    >> Share

    
    
16. QIN K, Liu Y, Xue L, Li H, et al
    Resting-state fMRI study on male patients with Parkinson's disease and with sexual dysfunction.
    Neuroscience. 2025 May 19:S0306-4522(25)00392.
    

    >> Share

    
    
17. GLASBAUER ND, Sookoian S, Pirola CJ
    Identifying molecular pathways of olfactory dysfunction in Parkinson's disease through a systems biology framework.
    Neuroscience. 2025 May 19:S0306-4522(25)00393.
    

    >> Share

    
    
18. RUST C, van den Heuvel LL, Bardien S, Carr J, et al
    Association between the relative abundance of butyrate-producing and mucin-degrading taxa and Parkinson's disease.
    Neuroscience. 2025;576:149-154.
    

    >> Share

    
    April 2025
19. GOLDBERG NRS, Haack AK, Meshul CK
    Retraction notice to "Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease" [Neuroscience 172 (2011) 443-452].
    Neuroscience. 2025 Apr 17:S0306-4522(25)00224.
    

    >> Share

    
    
20. PARACKA L, Heldmann M, Lange F, Saryyeva A, et al
    Subthalamic nucleus dynamics during executive functioning: Insights from local field potentials in Parkinson's disease.
    Neuroscience. 2025 Apr 8:S0306-4522(25)00283.
    

    >> Share

    
    
21. MEHREEN M, Ali M, Tariq H, Noor A, et al
    Chenodeoxycholic Acid-Mediated neuroprotection via alpha-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson's disease.
    Neuroscience. 2025;573:442-450.
    

    >> Share

    
    March 2025
22. LAU F, Binacchi R, Brugnara S, Cumplido-Mayoral A, et al
    Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer's and Parkinson's disease.
    Neuroscience. 2025 Mar 26:S0306-4522(25)00244.
    

    >> Share

    
    
23. SHARMA V, Unjum Saqib BZ, Aran KR
    Leptin as a potential neuroprotective target in Parkinson's Disease: Exploring its role in Neuroinflammation, oxidative Stress, and dopaminergic neurodegeneration.
    Neuroscience. 2025;572:134-144.
    

    >> Share

    
    
24. GOLDBERG NRS, Haack AK, Meshul CK
    Retraction notice to "Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease" [Neuroscience 172 (2011) 443-452].
    Neuroscience. 2025;571:31.
    

    >> Share

    
    February 2025
25. ZHANG T, Jin Z, Chen K, Pei G, et al
    Characteristics of multimodal physiological signal differences in symptom fluctuations in Parkinson's disease.
    Neuroscience. 2025;569:322-330.
    

    >> Share

    
    January 2025
26. ZUO Y, Ding X, Liu Z, Xie Y, et al
    Diverse pathways for the treatment of Parkinson's disease: Integration and development of traditional and emerging therapies.
    Neuroscience. 2025 Jan 26:S0306-4522(25)00057.
    

    >> Share

    
    
27. ZHENG D, Chen J
    MicroRNAs in Parkinson's disease: From pathogenesis to diagnostics and therapeutic strategies.
    Neuroscience. 2025;568:298-313.
    

    >> Share

    
    
28. BERGAMINO M, Fuentes A, Sandoval IM, Marmion DJ, et al
    Assessment of complementary white matter microstructural changes and grey matter atrophy in the 6-OHDA-induced model of Parkinson's disease.
    Neuroscience. 2025;568:2-11.
    

    >> Share

    
    
29. LIU M, Wang J, Wang R, Sun F, et al
    MRI evaluation of neuroprotective effects of Astragaloside ? on rotenone-induced late-stage Parkinson's disease mice.
    Neuroscience. 2025 Jan 4:S0306-4522(24)00753.
    

    >> Share

    
    December 2024
30. YIN N, Li P, Li X, Li X, et al
    Increased alpha-synuclein phosphorylation and oligomerization and altered enzymes in plasma of patients with Parkinson's disease.
    Neuroscience. 2024 Dec 30:S0306-4522(24)00763.
    

    >> Share

    
    
31. DWIVEDI A, Kumar A, Faruq M, Singh VK, et al
    Co-occurrence of Parkinson's disease and Retinitis Pigmentosa: A genetic and in silico analysis.
    Neuroscience. 2024;565:519-526.
    

    >> Share

    
    
32. ABSALYAMOVA M, Traktirov D, Burdinskaya V, Artemova V, et al
    Molecular basis of the development of Parkinson's disease.
    Neuroscience. 2024;565:292-300.
    

    >> Share

    
    November 2024
33. XIAO K, Li J, Zhou L, Liu X, et al
    Retinopathy in Parkinson's disease: A potential biomarker for early diagnosis and clinical assessment.
    Neuroscience. 2024 Nov 29:S0306-4522(24)00692.
    

    >> Share

    
    
34. ZHAO X, Xiao P, Gui H, Xu B, et al
    Combined graph convolutional networks with a multi-connection pattern to identify tremor-dominant Parkinson's disease and Essential tremor with resting tremor.
    Neuroscience. 2024;563:239-251.
    

    >> Share

    
    
35. LI H, Li C, Ma W, Qin K, et al
    Eye movement disorders: A new approach to preliminary screening of Parkinson's disease.
    Neuroscience. 2024;563:202-211.
    

    >> Share

    
    
36. MI X, Li M, Zhang Y, Qu L, et al
    Intracerebroventricular injection of alpha-synuclein preformed fibrils do not induce motor and olfactory impairment in C57BL/6 mice.
    Neuroscience. 2024;559:293-301.
    

    >> Share

    
    
37. YUAN J, Dong X, Zhou S, Nao J, et al
    Pharmacological activities and therapeutic potential of Hyperoside in the treatment of Alzheimer's and Parkinson's diseases: A systemic review.
    Neuroscience. 2024 Nov 1:S0306-4522(24)00565.
    

    >> Share

    
    October 2024
38. MAHONEY-RAFFERTY EC, Tucker HR, Akhtar K, Herlihy R, et al
    Corrigendum to "Assessing the location, relative expression and subclass of dopamine receptors in the cerebellum of hemi-parkinsonian rats" [Neuroscience 521 (2023) 1-19].
    Neuroscience. 2024 Oct 25:S0306-4522(24)00561.
    

    >> Share

    
    
39. LIANG X, Wen Y, Feng C, Xu L, et al
    Neuroglobin protects dopaminergic neurons in a Parkinson's cell model by interacting with mitochondrial complex NDUFA10.
    Neuroscience. 2024;562:43-53.
    

    >> Share

    
    
40. LEE HM, Lee DH, Lee HG, Kwon S, et al
    Functional neural substrates of Parkinson's disease and potential underpinnings of acute responses to acupuncture stimulation.
    Neuroscience. 2024 Oct 22:S0306-4522(24)00534.
    

    >> Share

    
    September 2024
41. MAO Z, Zhang Y, Liang Y, Xia C, et al
    Liver?X?receptor alpha contribution to neuroinflammation and glial cells activation induced by MPTP: Implications for Parkinson's disease.
    Neuroscience. 2024 Sep 19:S0306-4522(24)00485.
    

    >> Share

    
    
42. KUMAR BEURA S, Yadav P, Ramachandra Panigrahi A, Sahoo G, et al
    Impact of 6-Hydroxydopamine on Agonist-Induced human platelet functional Parameters: An explanation for platelet impairment in Parkinson's disease.
    Neuroscience. 2024 Sep 9:S0306-4522(24)00466.
    

    >> Share

    
    August 2024
43. CIERI F, Giriprakash PP, Nandy R, Zhuang X, et al
    Functional connectivity differences of the olfactory network in Parkinson's Disease, mild cognitive impairment and cognitively normal individuals: A resting-state fMRI study.
    Neuroscience. 2024 Aug 21:S0306-4522(24)00428.
    

    >> Share

    
    
44. MEILAN S, Song W, Oumei C, Kai X, et al
    Constipation is associated with emotional and cognitive impairment in patients with Parkinson's disease: a clinical and brain functional study.
    Neuroscience. 2024 Aug 19:S0306-4522(24)00413.
    

    >> Share

    
    
45. LUO H, Yu X, Li P, Hu J, et al
    Different neurotoxicity and seeding activity between alpha-synuclein oligomers formed in plasma of patients with Parkinson's disease and multiple system atrophy.
    Neuroscience. 2024;557:1-11.
    

    >> Share

    
    July 2024
46. DUNCAN SJ, Marques K, Fawkes J, Smith LJ, et al
    Galvanic Vestibular Stimulation Modulates EEG Markers of Voluntary Movement in Parkinson's Disease.
    Neuroscience. 2024 Jul 27:S0306-4522(24)00368.
    

    >> Share

    
    
47. ANANDHAN A, Janakiraman U, Manivasagam T
    RETRACTED: "Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease" [Neurosci. 218 (2012) 25
    Neuroscience. 2024 Jul 26:S0306-4522(24)00365.
    

    >> Share

    
    
48. LIU T, Li J, Sun L, Zhu C, et al
    The role of ACE2 in RAS axis on microglia activation in Parkinson's disease.
    Neuroscience. 2024 Jul 8:S0306-4522(24)00281.
    

    >> Share

    
    June 2024
49. HUANG M, Yu H, Lyu X, Pu W, et al
    Region-specific cerebral metabolic alterations in Parkinson's disease patients with/without mild cognitive impairment.
    Neuroscience. 2024 Jun 5:S0306-4522(24)00241.
    

    >> Share

    
    
50. KUMARI S, Rana B, Senthil Kumaran S, Chaudhary S, et al
    Gray matter atrophy in a 6-OHDA-induced model of Parkinson's disease.
    Neuroscience. 2024 Jun 4:S0306-4522(24)00229.
    

    >> Share

    
    May 2024
51. DA SILVA OLIVEIRA B, Cristina de Brito Toscano E, Katharina Sabino Abreua L, de Barros Fernandes H, et al
    Nigrostriatal inflammation is associated with nonmotor symptoms in an experimental model of prodromal Parkinson's disease.
    Neuroscience. 2024 May 13:S0306-4522(24)00205.
    

    >> Share

    
    
52. HUANG W, Zhang T, Li X, Gong L, et al
    Intranasal administration of umbilical cord mesenchymal stem cell exosomes alleviates Parkinson's disease.
    Neuroscience. 2024 May 3:S0306-4522(24)00169.
    

    >> Share

    
    April 2024
53. FASCIANI I, Petragnano F, Bono F, Aloisi G, et al
    In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons.
    Neuroscience. 2024;544:104-116.
    

    >> Share

    
    March 2024
54. SALLY SAMSON J, Ramesh A, Deepa Parvathi V
    Development of midbrain dopaminergic neurons and the advantage of using hiPSCs as a model system to study Parkinson's disease.
    Neuroscience. 2024 Mar 22:S0306-4522(24)00138.
    

    >> Share

    
    
55. DENG HW, Li BR, Zhou SD, Luo C, et al
    Revealing Novel Genes Related to Parkinson's Disease Pathogenesis and Establishing an associated Model.
    Neuroscience. 2024;544:64-74.
    

    >> Share

    
    
56. ZHU D, Zhang S, Wang X, Xiao C, et al
    Secretory Clusterin Inhibits Dopamine Neuron Apoptosis in MPTP Mice by Preserving Autophagy Activity.
    Neuroscience. 2024;540:38-47.
    

    >> Share

    
    November 2023
57. MANSOUR HM, Mohamed AF, Khattab MM, El-Khatib AS, et al
    Heat Shock Protein 90 in Parkinson's disease: Profile of a serial killer.
    Neuroscience. 2023 Nov 29:S0306-4522(23)00532.
    

    >> Share

    
    October 2023
58. SUBRAMANIYAN S, Briget Kuriakose B, Mushfiq S, Marimuthu Prabhu N, et al
    Gene signals and SNPs associated with Parkinson's disease: A nutrigenomics and computational prospective insights.
    Neuroscience. 2023 Oct 17:S0306-4522(23)00457.
    

    >> Share

    
    
59. DZOLJIC E, Saric Matutinovic M, Stojkovic O, Velickovic J, et al
    Vitamin D serum levels and vitamin D receptor genotype in patients with Parkinson's disease.
    Neuroscience. 2023 Oct 11:S0306-4522(23)00454.
    

    >> Share

    
    September 2023
60. HUANG J, Yuan X, Chen L, Hu B, et al
    The biology, pathological roles of exosomes and their clinical application in Parkinson(')s disease.
    Neuroscience. 2023 Sep 7:S0306-4522(23)00409.
    

    >> Share

    
    July 2023
61. ZHOU L, Li Y, Wang M, Han W, et al
    Disruption of alpha-Synuclein Proteostasis in the Striatum and Midbrain of Long-term Ovariectomized Female Mice.
    Neuroscience. 2023;523:80-90.
    

    >> Share

    
    
62. YUAN Y, Zhang X, Wu Y, Lian P, et al
    ONO-2506 Can Delay Levodopa-induced Dyskinesia in the Early Stage.
    Neuroscience. 2023;523:61-79.
    

    >> Share

    
    June 2023
63. PEDRO AMORIM NETO D, Vitor Pereira de Godoy J, Tostes K, Pelegrini Bosque B, et al
    Metabolic disturbances in the gut-brain axis of a mouse model of MPTP-induced Parkinsonism evaluated by Nuclear Magnetic Resonance.
    Neuroscience. 2023 Jun 16:S0306-4522(23)00266.
    

    >> Share

    
    
64. PU Z, Liu S, Guo Z, Zhang X, et al
    Casein Reactivates Dopaminergic Nerve Injury and Intestinal Inflammation with Disturbing Intestinal Microflora and Fecal Metabolites in a Convalescent Parkinson's Disease Mouse Model.
    Neuroscience. 2023 Jun 13:S0306-4522(23)00225.
    

    >> Share

    
    April 2023
65. MAHONEY-RAFFERTY EC, Tucker HR, Akhtar K, Herlihy R, et al
    Assessing the Location, Relative Expression and Subclass of Dopamine Receptors in the Cerebellum of Hemi-Parkinsonian Rats.
    Neuroscience. 2023 Apr 26:S0306-4522(23)00143.
    

    >> Share

    
    March 2023
66. KANDIL EA, Abdelkader NF, El-Sayeh BM, Saleh S, et al
    Corrigendum to "Imipramine and Amitriptyline Ameliorate the Rotenone Model of Parkinson's Disease in Rats" [Neuroscience 332 (2016) 26-37].
    Neuroscience. 2023 Mar 6:S0306-4522(23)00120.
    

    >> Share

    
    February 2023
67. LOU T, Tao B, Chen M
    Relationship of Apolipoprotein E with Alzheimer's Disease and Other Neurological Disorders: An Updated Review.
    Neuroscience. 2023 Feb 2:S0306-4522(23)00055.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share